Acipimox Administration With Exercise Induces a Co-feedback Action of the GH, PP, and PYY on Ghrelin Associated With a Reduction of Peripheral Lipolysis in Bulimic and Healthy-Weight Czech Women: A Randomized Study

Anti-lipolytic drugs and exercise are enhancers of growth hormone (GH) secretion. Decreased circulating free fatty acids (FFA) have been proposed to exert ghrelin-GH feedback loop after administration of an anti-lipolytic longer-acting analog of nicotinic acid, Acipimox (OLB, 5-Methylpyrazine-2-carb...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 10; p. 108
Main Authors Smitka, Kvido, Nedvidkova, Jara, Vondra, Karel, Hill, Martin, Papezova, Hana, Hainer, Vojtech
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 12.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anti-lipolytic drugs and exercise are enhancers of growth hormone (GH) secretion. Decreased circulating free fatty acids (FFA) have been proposed to exert ghrelin-GH feedback loop after administration of an anti-lipolytic longer-acting analog of nicotinic acid, Acipimox (OLB, 5-Methylpyrazine-2-carboxylic acid 4-oxide, molecular weight of 154.1 Da). OLB administration strongly suppresses plasma FFA during exercise. Neuroendocrine perturbations of the adipose tissue (AT), gut, and brain peptides may be involved in the etiopathogenesis of eating disorders including bulimia nervosa (BN) and anorexia nervosa. BN is characterized by binge eating, self-induced vomiting or excessive exercise. To test the hypothesis that treatment with OLB together with exercise vs. exercise alone would induce feedback action of GH, pancreatic polypeptide (PP), peptide tyrosine tyrosine (PYY), and leptin on ghrelin in Czech women with BN and in healthy-weight Czech women (HW). The lipolysis rate (as glycerol release) in subcutaneous abdominal AT was assessed with microdialysis. At an academic medical center, 12 BN and 12 HW (the control group) were randomized to OLB 500 mg 1 h before a single exercise bout (45 min, 2 W/kg of lean body mass [LBM]) once a week vs. identical placebo over a total of 2 weeks. Blood plasma concentrations of GH, PP, PYY, leptin, ghrelin, FFA, glycerol, and concentrations of AT interstitial glycerol were estimated during the test by RIA utilizing I-labeled tracer, the electrochemiluminescence technique (ECLIA) or colorimetric kits. OLB administration together with short-term exercise significantly increased plasma GH ( < 0.0001), PP ( < 0.0001), PYY, and leptin concentrations and significantly decreased plasma ghrelin ( < 0.01) concentrations in both groups, whereas short-term exercise with placebo resulted in plasma ghrelin ( < 0.05) decrease exclusively in BN. OLB administration together with short-term exercise significantly lowered local subcutaneous abdominal AT interstitial glycerol ( < 0.0001) to a greater extent in BN. OLB-induced suppression of plasma ghrelin concentrations together with short-term exercise and after the post-exercise recovering phase suggests a potential negative co-feedback of GH, PP, PYY, and leptin on ghrelin secretion to a greater extent in BN. Simultaneously, the exercise-induced elevation in AT interstitial glycerol leading to a higher inhibition of peripheral lipolysis by OLB in BN. www.ClinicalTrials.gov, identifier NCT03338387.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Nils Lambrecht, University of California, Irvine, United States; Gina Leinninger, Michigan State University, United States
This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology
Edited by: Jacques Epelbaum, Institut National de la Santé et de la Recherche Médicale (INSERM), France
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2019.00108